Reata Pharmaceuticals Inc (RETA) Insider Trading
- $55,768,606.72
- $118,445,653.71
- Sept. 14, 2023
- Elaine Castellanos
Trader Name | Date | Title | Amount | Price | Type | Total Value |
---|---|---|---|---|---|---|
Feb. 5, 2019 | CFO | 3,000 | $80.00 | Sell | $240,000.00 | |
Feb. 1, 2019 | CFO | 7,000 | $80.00 | Sell | $560,000.00 | |
Jan. 31, 2019 | Insider | 4,150 | $76.70 | Sell | $318,305.00 | |
Jan. 15, 2019 | CFO | 4,000 | $71.15 | Sell | $284,600.00 | |
Jan. 7, 2019 | CFO | 20,000 | $72.04 | Sell | $1,440,800.00 | |
Jan. 2, 2019 | Insider | 4,150 | $53.99 | Sell | $224,058.50 | |
Dec. 20, 2018 | Director | 888 | $52.12 | Buy | $46,282.56 | |
Dec. 12, 2018 | Director | 110,826 | $59.41 | Buy | $6,584,172.66 | |
Dec. 12, 2018 | Major Shareholder | 1,418 | $59.90 | Buy | $84,938.20 | |
Dec. 10, 2018 | Major Shareholder | 56,599 | $58.77 | Buy | $3,326,323.23 | |
Nov. 16, 2018 | Director | 1,679 | $59.33 | Buy | $99,615.07 | |
Nov. 7, 2018 | Insider | 4,750 | $66.97 | Sell | $318,107.50 | |
Nov. 1, 2018 | Insider | 4,750 | $59.48 | Sell | $282,530.00 | |
Oct. 23, 2018 | Insider | 14,250 | $57.08 | Sell | $813,390.00 | |
July 25, 2018 | Director | 888 | $78.34 | Buy | $69,565.92 | |
July 23, 2018 | Insider | 7,336 | $50.81 | Sell | $372,742.16 | |
July 5, 2018 | Insider | 4,750 | $36.62 | Sell | $173,945.00 | |
June 5, 2018 | Insider | 28,500 | $36.62 | Sell | $1,043,670.00 | |
Dec. 29, 2017 | Director | 17,000 | $28.47 | Buy | $483,990.00 | |
Dec. 29, 2017 | Major Shareholder | 17,000 | $28.47 | Buy | $483,990.00 | |
Dec. 28, 2017 | Major Shareholder | 27,200 | $25.93 | Buy | $705,296.00 | |
Dec. 27, 2017 | Director | 15,000 | $25.83 | Buy | $387,450.00 | |
Dec. 26, 2017 | Major Shareholder | 12,000 | $26.06 | Buy | $312,720.00 | |
Dec. 14, 2017 | Director | 200,000 | $24.79 | Buy | $4,958,000.00 | |
Dec. 13, 2017 | Major Shareholder | 121,725 | $24.88 | Buy | $3,028,518.00 | |
Nov. 15, 2017 | Director | 3,888 | $24.02 | Buy | $93,389.76 | |
Aug. 1, 2017 | Director | 8,064 | $31.00 | Buy | $249,984.00 | |
June 14, 2017 | Major Shareholder | 61,000 | $25.11 | Sell | $1,531,710.00 | |
June 13, 2017 | Major Shareholder | 11,389 | $25.47 | Sell | $290,077.83 | |
June 12, 2017 | Major Shareholder | 222,503 | $25.71 | Sell | $5,720,552.13 | |
June 7, 2017 | Major Shareholder | 89,497 | $28.24 | Sell | $2,527,395.28 | |
June 6, 2017 | Major Shareholder | 64,170 | $28.09 | Sell | $1,802,535.30 | |
June 5, 2017 | Major Shareholder | 23,327 | $28.67 | Sell | $668,785.09 | |
March 28, 2017 | Major Shareholder | 450,000 | $22.50 | Sell | $10,125,000.00 | |
Dec. 30, 2016 | Director | 9,392 | $21.72 | Buy | $203,994.24 | |
Dec. 16, 2016 | Director | 164,753 | $22.99 | Buy | $3,787,671.47 | |
Dec. 15, 2016 | Major Shareholder | 8,889 | $21.57 | Buy | $191,735.73 | |
Dec. 14, 2016 | Director | 5,000 | $21.76 | Buy | $108,800.00 | |
Aug. 22, 2016 | Director | 1,780 | $17.00 | Buy | $30,260.00 | |
Aug. 18, 2016 | Director | 308,220 | $17.08 | Buy | $5,264,397.60 | |
Aug. 16, 2016 | Insider | 7,000 | $16.26 | Buy | $113,820.00 | |
June 30, 2016 | Major Shareholder | 164,600 | $19.78 | Buy | $3,255,788.00 | |
June 27, 2016 | Director | 73,403 | $19.26 | Buy | $1,413,741.78 | |
June 7, 2016 | Director | 24,220 | $17.57 | Buy | $425,545.40 | |
June 1, 2016 | Insider | 114,000 | $11.00 | Buy | $1,254,000.00 | |
June 1, 2016 | Major Shareholder | 750,000 | $11.00 | Buy | $8,250,000.00 | |
June 1, 2016 | Director | 251,553 | $12.70 | Buy | $3,194,723.10 |
Insiders are both buying and selling Reata Pharmaceuticals Inc stock.
The insider traders at Reata Pharmaceuticals Inc are: Elaine Castellanos, Jason Douglas Wilson, James W Traweek Jr, Keith Wayne Ward, A/S Novo, James Edward Bass, R Kent Mcgaughy Jr, Cpmg Inc, Manmeet Singh Soni, Andrea Loewen, James Warren Huff, Dawn Carter Bir, Bhaskar Anand, Shamim Ruff, Colin John Meyer, Michael D Wortley, Jack Nielsen, Samina Khan, and Abbvie Inc.
The most active insider trader at Reata Pharmaceuticals Inc is Elaine Castellanos with 15 trades.
Manmeet Singh Soni has sold the most Reata Pharmaceuticals Inc stock with a total value of $34,861,345.96.
James W Traweek Jr has bought the most Reata Pharmaceuticals Inc stock with a total value of $26,109,097.16.
The most recent insider trade for Reata Pharmaceuticals Inc was on Sept. 14, 2023.
The single biggest insider buy for Reata Pharmaceuticals Inc was from A/S Novo with a total value of $8,250,000.00 on June 1, 2016.
The single biggest insider sell for Reata Pharmaceuticals Inc was from James Warren Huff with a total value of $14,290,791.57 on Nov. 10, 2020.